
Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company provides products for diseases, including hematology, oncology, immunology, cardiovascular, neuroscience, and Covid-19.
The company’s strong third-quarter results reflect solid growth in its existing and new product portfolios. It continues to progress its pipeline and achieve significant regulatory and clinical milestones.